Voyageur Pharmaceuticals Ltd.
Financial Statements (IFRS) · Amounts in CAD
Income Statement
Balance Sheet
Cash Flow
| Line Item | Q2 2025May 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 | Q2 2024May 31, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 320,208 | 629,610 | 294,115 | 249,390 | 404,536 |
| General And Administrative Expense | 320,208 | 629,610 | 294,115 | 249,390 | 404,536 |
| Research And Development | 54,443 | 40,465 | 105,618 | 64,365 | 104,823 |
| Depreciation And Amortization In Income Statement | 283.00 | 283.00 | 392.00 | 393.00 | 393.00 |
| Other Operating Expenses | 169,323 | 147,201 | 50,447 | 44,982 | 52,150 |
| Operating Expense | 544,257 | 817,559 | 450,572 | 359,130 | 561,902 |
| Operating Income | -544,257 | -817,559 | -450,572 | -359,130 | -561,902 |
| EBIT | -544,257 | -817,559 | -458,513 | -359,130 | -561,902 |
| Pretax Income | -544,257 | -817,559 | -458,513 | -359,130 | -561,902 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -544,258 | -817,559 | -458,512 | -359,130 | -561,902 |
| Net Income From Continuing Operation Net Minority Interest | -544,258 | -817,559 | -458,512 | -359,130 | -561,902 |
| Net Income Including Noncontrolling Interests | -544,257 | -817,559 | -458,513 | -359,130 | -561,902 |
| Net Income Common Stockholders | -544,258 | -817,559 | -458,512 | -359,130 | -561,902 |
| Net Income | -544,258 | -817,559 | -458,512 | -359,130 | -561,902 |
| EBITDA | -543,973 | -817,276 | -458,121 | -358,737 | -561,509 |
| Normalized EBITDA | -543,973 | -817,276 | -458,121 | -358,737 | -561,509 |
| Reconciled Depreciation | 284.00 | 283.00 | 392.00 | 393.00 | 392.00 |
| Basic EPS | 0.00 | -0.01 | -- | 0.00 | 0.00 |
| Diluted EPS | 0.00 | -0.01 | -- | 0.00 | 0.00 |
| Basic Average Shares | 161.2M | 155.5M | -- | 139.4M | 138.9M |
| Diluted Average Shares | 161.2M | 155.5M | -- | 139.4M | 138.9M |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -544,258 | -817,559 | -458,512 | -359,130 | -561,902 |
| Depreciation Amortization Depletion Income Statement | 283.00 | 283.00 | 392.00 | 393.00 | 393.00 |
| Depreciation Income Statement | 283.00 | 283.00 | 392.00 | 393.00 | 393.00 |
| Diluted NI Availto Com Stockholders | -544,258 | -817,559 | -458,512 | -359,130 | -561,902 |
| Net Income Continuous Operations | -544,257 | -817,559 | -458,513 | -359,130 | -561,902 |
| Other Gand A | 108,210 | 158,493 | 175,111 | 137,114 | 69,220 |
| Salaries And Wages | 211,998 | 471,117 | 119,004 | 112,276 | 335,316 |
| Total Expenses | 544,257 | 817,559 | 450,572 | 359,130 | 561,902 |
| Line Item | Q2 2025May 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 | Q2 2024May 31, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 378,385 | 638,985 | 165,569 | 3,035 | 13,169 |
| Cash Cash Equivalents And Short Term Investments | 378,385 | 638,985 | 165,569 | 3,035 | 13,169 |
| Accounts Receivable | 86,456 | 70,056 | 52,068 | 37,493 | 27,021 |
| Receivables | 86,456 | 70,056 | 52,068 | 37,493 | 27,021 |
| Inventory | 84,704 | 66,824 | 66,824 | 10,323 | 10,323 |
| Prepaid Assets | 98,803 | 99,859 | 74,164 | 79,154 | 125,133 |
| Current Assets | 648,348 | 875,724 | 358,625 | 130,005 | 175,646 |
| Gross PPE | 2.3M | 2.3M | 2.2M | 2.2M | 2.1M |
| Accumulated Depreciation | -14,613 | -14,329 | -14,046 | -13,654 | -13,261 |
| Net PPE | 2.3M | 2.3M | 2.2M | 2.2M | 2.1M |
| Other Non Current Assets | 14,000 | 14,000 | 14,000 | 14,000 | 14,000 |
| Total Non Current Assets | 2.3M | 2.3M | 2.2M | 2.2M | 2.1M |
| Total Assets | 3.0M | 3.2M | 2.6M | 2.3M | 2.3M |
| Payables And Accrued Expenses | 1.7M | 1.6M | 1.9M | 1.3M | 1.0M |
| Current Deferred Revenue | 282,457 | 350,000 | -- | -- | -- |
| Other Current Liabilities | -- | -- | 167,000 | -- | -- |
| Current Liabilities | 2.0M | 1.9M | 2.1M | 1.3M | 1.0M |
| Long Term Debt | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 |
| Long Term Debt And Capital Lease Obligation | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 |
| Other Non Current Liabilities | -1.00 | -- | -- | -- | -- |
| Total Non Current Liabilities Net Minority Interest | 53,999 | 54,000 | 54,000 | 54,000 | 54,000 |
| Total Liabilities Net Minority Interest | 2.0M | 2.0M | 2.1M | 1.4M | 1.1M |
| Common Stock | 10.9M | 10.7M | 9.1M | 9.2M | 9.1M |
| Capital Stock | 10.9M | 10.7M | 9.1M | 9.2M | 9.1M |
| Additional Paid In Capital | 2.2M | 2.2M | 2.1M | 2.1M | 2.1M |
| Retained Earnings | -12.2M | -11.7M | -10.8M | -10.4M | -10.0M |
| Gains Losses Not Affecting Retained Earnings | 16,700 | 30,208 | 20,931 | 17,758 | 13,364 |
| Other Equity Adjustments | 16,700 | 30,208 | 20,931 | 17,758 | 13,364 |
| Common Stock Equity | 913,664 | 1.2M | 449,958 | 944,818 | 1.2M |
| Stockholders Equity | 913,664 | 1.2M | 449,958 | 944,818 | 1.2M |
| Total Equity Gross Minority Interest | 913,664 | 1.2M | 449,958 | 944,818 | 1.2M |
| Total Capitalization | 953,664 | 1.2M | 489,958 | 984,818 | 1.3M |
| Net Tangible Assets | 913,664 | 1.2M | 449,958 | 944,818 | 1.2M |
| Tangible Book Value | 913,664 | 1.2M | 449,958 | 944,818 | 1.2M |
| Working Capital | -1.3M | -1.0M | -1.7M | -1.2M | -848,369 |
| Invested Capital | 953,664 | 1.2M | 489,958 | 984,818 | 1.3M |
| Total Debt | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 |
| Net Debt | -- | -- | -- | 36,965 | 26,831 |
| Share Issued | 162.7M | 160.6M | 139.5M | 139.5M | 138.9M |
| Ordinary Shares Number | 162.7M | 160.6M | 139.5M | 139.5M | 138.9M |
| Current Deferred Liabilities | 282,457 | 350,000 | -- | -- | -- |
| Finished Goods | 81,079 | 63,199 | 63,199 | -- | -- |
| Long Term Provisions | 14,000 | 14,000 | 14,000 | 14,000 | 14,000 |
| Other Properties | 2.3M | 2.3M | 2.2M | 2.2M | 2.1M |
| Raw Materials | 3,625 | 3,625 | 3,625 | -- | -- |
| Line Item | Q2 2025May 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 | Q2 2024May 31, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -260,689 | -1.4M | 81,141 | 39,219 | -189,292 |
| Cash Flow From Continuing Operating Activities | -260,688 | -1.4M | 81,142 | 39,219 | -189,292 |
| Depreciation And Amortization | 284.00 | 283.00 | 392.00 | 393.00 | 392.00 |
| Depreciation Amortization Depletion | 284.00 | 283.00 | 392.00 | 393.00 | 392.00 |
| Stock Based Compensation | 298,665 | 395,295 | 79,950 | 73,163 | 239,552 |
| Change In Working Capital | -1,878 | -966,151 | 456,473 | 324,291 | 127,053 |
| Changes In Account Receivables | -- | -17,988 | -- | -- | -- |
| Change In Receivables | -16,400 | -17,988 | -14,575 | -10,472 | -9,158 |
| Change In Inventory | -17,880 | 0.00 | -56,501 | 0.00 | 0.00 |
| Change In Payables And Accrued Expense | 31,346 | -922,468 | 522,559 | 288,784 | 89,877 |
| Investing Cash Flow | -20,543 | -42,429 | -35,321 | -54,987 | -38,102 |
| Cash Flow From Continuing Investing Activities | -20,543 | -42,429 | -35,321 | -54,987 | -38,102 |
| Issuance Of Capital Stock | 0.00 | 913,881 | 167,000 | 530.00 | -5,634 |
| Net Common Stock Issuance | 0.00 | 913,881 | 167,000 | 530.00 | -5,634 |
| Financing Cash Flow | 20,633 | 1.9M | 116,714 | 5,634 | -9,188 |
| Cash Flow From Continuing Financing Activities | 20,633 | 1.9M | 116,714 | 5,634 | -9,188 |
| Changes In Cash | -260,600 | 473,416 | 162,534 | -10,134 | -236,582 |
| Beginning Cash Position | 638,985 | 165,569 | 3,035 | 13,169 | 249,751 |
| End Cash Position | 378,385 | 638,985 | 165,569 | 3,035 | 13,169 |
| Free Cash Flow | -260,689 | -1.4M | 81,141 | 39,219 | -189,292 |
| Change In Prepaid Assets | 1,056 | -25,695 | 4,990 | 45,979 | 46,334 |
| Common Stock Issuance | 0.00 | 913,881 | 167,000 | 530.00 | -5,634 |
| Depreciation | 284.00 | 283.00 | 392.00 | 393.00 | 392.00 |
| Net Foreign Currency Exchange Gain Loss | -13,508 | 9,277 | -5,102 | 4,394 | 472.00 |
| Net Income From Continuing Operations | -544,251 | -817,559 | -458,512 | -357,388 | -562,395 |
| Net Other Financing Charges | -69,543 | 283,919 | 0.00 | 0.00 | -3,554 |
| Net Other Investing Changes | -20,543 | -42,429 | -35,321 | -54,987 | -38,102 |
| Operating Gains Losses | -13,508 | 9,277 | -5,102 | -1,240 | 6,106 |
| Proceeds From Stock Option Exercised | 90,176 | 696,899 | -50,286 | 55,390 | 0.00 |